Shaperon

378800 · KOSDAQ · Health Care · SMALL CAP

Provisional Q3 2026 results.

Shaperon filed provisional (unaudited) consolidated results for Q3 2026: revenue of US$3.51M (+2739.9% year on year).

Earnings(Operating results (consolidated) (preliminary) (fair disclosure))· FILED 2026-10-01· RCEPT 20261001900342

US$3.51MRevenue
+2739.9%Revenue vs a year earlier

Converted at 1 USD ≈ ₩1,360.59 (filing-date rate, 2026-10-01 close)

What happened

Shaperon filed provisional (unaudited) consolidated results for Q3 2026: revenue of US$3.51M (+2739.9% year on year).

These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.

RevenueUS$3.51M
Revenue vs a year earlier+2739.9%
PeriodQ3 2026 (consolidated)
Filed2026-10-01, Operating results (consolidated) (preliminary) (fair disclosure)
SourceDART rcept 20261001900342 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-10-01 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.